Bibliography
- SEER website. SEER Cancer Statistics Review, 1975-2005, based on November 2007 SEER data submission. Ries LAG, Melbert D, Krapcho M, et al. (editors). National Cancer Institute. Bethesda. Available from: http://seer.cancer.gov/csr/1975_2005 [Last accessed 2008]
- Byers T, Nestle M, McTiernan A, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2002;52(2):92-119
- Weinstein IB. The contributions of molecular biology to cancer epidemiology. Ann NY Acad Sci 1995;768:30-40
- Goss KH, Groden J. Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 2000;18:1967-79
- Smith G, Stanley LA, Sim E, et al. Metabolic polymorphisms and cancer susceptibility. Cancer Surveys 1995;25:27-65
- Alberts DS, Colvin MO, Conney AH, et al. Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research. Cancer Res 1999;59:4743-58
- Kurahashi N, Inoue M, Iwasaki M, et al. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev 2008;7:930-7
- Wetherill YB, Fisher NL, Stauback A, et al. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status. Cancer Res 2005;65:54-65
- Dairkee SH, Seok J, Champion S, et al. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res 2008;68:2076-80
- Crowell JA. The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: an overview. Eur J Cancer 2005;41:1889-910
- Americans for Nonsmokers' Rights. Available from: http://www.no-smoke.org/ [Last accessed 6 May 2008]
- Cole MP, Jones CT, Todd ID. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Brit J Cancer 1971;25:270-5
- Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88
- Jordan VC. Tamoxifen: a personal retrospective. Lancet Oncol 2000;1:43-9
- Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86
- Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13
- Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 1999;281:2189-97
- Langman MJ, Cheng KK, Gilman EA, et al. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ (Clinical Res Ed) 2000;320:1642-6
- Goel A, Chang DK, Ricciardiello L, et al. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res 2003;9:383-90
- Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6
- Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6
- Wolfe MM, Future trends in the development of safer nonsteroidal anti-inflammatory drugs. Am J Med 1998;105(5A):44S-52S
- Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 2000;1470:M69-78
- Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179-84
- Lahlou M. Screening of natural products for drug discovery. Expert Opin Drug Discov 2007;2:697-705
- Wattenberg LW. Chemoprophylaxis of carcinogenesis: a review. Cancer Res 1966;26:1520-6
- Yamori Y, Miura A, Taira K. Implications from and for food cultures for cardiovascular diseases: Japanese food, particularly Okinawan diets. Asia Pac J Clin Nutr 2001;10:144-5
- Simopoulos AP. The Mediterranean diets: what is so special about the diet of Greece? The scientific evidence. J Nutr 2001;131(Suppl):S3065-73
- Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 1991;18(Suppl 1):S11-7
- Ursin G, Bernstein L, Pike MC. Breast cancer. Cancer Surveys 1994;19-20:241-64
- Wu AH, Ziegler RG, Nomura AM, et al. Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr 1998;68(Suppl):S1437-43
- Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann NY Acad Sci 2005;1056:206-17
- Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett 2007;255:170-81
- Plummer SM, Holloway KA, Manson MM, et al. Inhibition of cyclooxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 1999;18:6013-20
- Rao CV, Rivenson A, Simi B, et al. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 1995;55:259-66
- Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23:363-98
- Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003;43:89-143
- Thomasset SC, Berry DP, Garcea G, et al. Dietary polyphenolic phytochemicals – promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 2006;120:451-8
- Giovannucci E, Rimm EB, Liu Y, et al. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 2002;94:391-8
- Schwarz S, Obermuller-Jevic UC, Hellmis E, et al. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr 2008;138:49-53
- Michnovicz JJ, Bradlow HL. Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 1990;82:947-9
- Kim SO, Chun KS, Kundu JK, et al. Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. BioFactors 2004;21:27-31
- Ferraroni M, La Vecchia C, D'Avanzo B, et al. Selected micronutrient intake and the risk of colorectal cancer. Brit J Cancer 1994;70:1150-5
- Zhu S, Mason J, Shi Y, et al. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med J 2003;116:15-9
- Pezzuto JM. Resveratrol as an inhibitor of carcinogenesis. Pharm Biol 2008;46:443-573
- Deorukhkar A, Krishnan S, Sethi G, et al. Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Investig Drugs 2007;16:1753-73
- Moon TE, Levine N, Cartmel B, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemol Biomarkers Prev 1997;6:949-56
- Courtney ED, Matthews S, Finlayson C, et al. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis 2007;22:765-76
- Vijayakumar S, Boerner PS, Mehta RR, et al. Clinical trials using chemopreventive vitamin D analogs in breast cancer. Cancer J 2006;12:445-50
- Shukla Y, Kalra N. Cancer chemoprevention with garlic and its constituents. Cancer Lett 2006;247:167-81
- Wu AH, Wan P, Hankin J, et al. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002;23:1491-6
- Jarred RA, Keikha M, Dowling C, et al. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemol Biomarkers Prev 2002;11:1689-96
- Williams PG, Asoklar RN, Kondratyuk T, et al. Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola. J Nat Prod 2007;70:83-8
- University of Texas MD Anderson Cancer Personal Risk Check. Available from: https://www3.mdanderson.org/ publicedu/prevention/ [Last accessed 7 May 2008]
- Kelloff GJ, Schilsky RL, Alberts DS, et al. Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs. Clin Cancer Res 2004;10:3908-18
- Rustin GJS, Bast RC Jr, Kelloff GJ, et al. Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Clin Cancer Res 2004;10:3919-26
- Kelloff GJ, Coffey DS, Chabner BA, et al. Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer. Clin Cancer Res 2004;10:3927-3
- Boone CW, Bacus JW, Bacus JV, et al. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents. J Cell Biochem 1997;28-29:1-20
- Mohr S, Leikauf GD, Keith G, et al. Microarrays as cancer keys: an array of possibilities. J Clin Oncol 2002;20:3165-75
- Joint FDA. NCI program aims to streamline cancer drug development. FDA Consum 2003;37(4):11
- New Federal Health Initiative to Improve Cancer Therapy. Available from: http://www.cancer.gov/newscenter/pressreleases/OBQI [Last accessed 7 May 2008]
- Dubreuilh W. Epitheliomatose d'origine solaire. Ann Dermat Syphiliq 1908;45:387-416
- Boveri T. In zur frage der fntstehung maligner Tumoren 1-64, Jena, Gustav Fischer-Verlag; 1914
- Muller HJ. The production of mutations by X-rays. Proc Natl Acad Sci USA 1928;14:714-26
- Kennaway EL. Further experiments on cancer-producing substances. Biochem J 1930;24:497-504
- Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. BMJ 1950;2:739-48
- Cameron AB, Thabet RJ. Sigmoidoscopy as part of routine cancer clinic examinations with correlated fecal chemistry and colon cytologic studies. Surgery 1960;48:344-50
- Sporn MB, Dunlop NM, Newton DL, et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976;35:1332-8
- Kuriyama M, Wang MC, Papsidero LD, et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 1980;40:4658-62
- Blumberg BS, London WT. Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver. Cancer 1982;50(Suppl):2657-65
- Han J, Jiao L, Lu Y, et al. Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent. In Vivo 1990;4:153-60
- Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38
- Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71
- The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35
- Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70
- DeGrendele H. Benefit of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. Clin Breast Cancer 2003;4:311-2
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24
- Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004;364:1757-65
- Altundag K, Altundag O, Islam R, et al. Adjuvant trastuzumab use in high-risk breast cancer patients may prevent development of contralateral estrogen receptor-negative breast tumors. Med Hypotheses 2006;66:1045-6
- Lippman ME, Cummings SR, Disch DP, et al. Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk. Clin Cancer Res 2006;12:5242-7
- Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-43
- AACR Landmarks in Cancer Research. Available from: http://www.aacr.org/Uploads/DocumentRepository/2007_AM/Centennial_Landmarks/Landmarks_text.pdf [Last accessed 30 March 2008]
- NCI 100 Years of Advances Against Cancer. Available from: http://www.cancer.gov/cancertopics/factsheet/100yearsadvances [Last accessed 30 March 2008]
- NCI Division of Cancer Prevention Chemopreventive Agents. Available from: http://dcp.cancer.gov/programs-resources/resources/agents [Last accessed 7 May 2008]